Global Smart Inhaler Technology Market 2023-2027

Description

List of Tables

The smart inhaler technology market is forecasted to grow by USD 46.37 mn during 2022-2027, accelerating at a CAGR of 10.16% during the forecast period. The report on the smart inhaler technology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of respiratory diseases, growing demand for connected healthcare systems, and increasing healthcare expenditure.

Technavio's smart inhaler technology market is segmented as below:

Market Scope
Base Year	2022
End Year	2027
Series Year	2023-2027
Growth Momentum	Accelerate
YOY 2023	9.77%
CAGR	10.16%
Incremental Value	$46.37mn

By Product

Inhalers
Nebulizers

By Application

Asthma
COPD

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the availability of real-time feedback as one of the prime reasons driving the smart inhaler technology market growth during the next few years. Also, growing healthcare digitalization and rising technological advancements will lead to sizable demand in the market.

The report on the smart inhaler technology market covers the following areas:

Smart inhaler technology market sizing
Smart inhaler technology market forecast
Smart inhaler technology market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading smart inhaler technology market vendors that include 3M Co., Adherium Ltd., Amiko Digital Health Ltd., AptarGroup Inc., AstraZeneca Plc, Cognita Labs, Cohero Health Inc., Findair Sp. z o. o., Infineon Technologies AG, Novartis AG, OPKO Health Inc., ResMed Inc., Sensirion AG, Teva Pharmaceutical Industries Ltd., and Vectura Group plc. Also, the smart inhaler technology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR45828

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global smart inhaler technology market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global smart inhaler technology market 2017 - 2021 ($ million)
4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.3 Application Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Inhalers - Market size and forecast 2022-2027
Exhibit 34: Chart on Inhalers - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Inhalers - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Inhalers - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Inhalers - Year-over-year growth 2022-2027 (%)
6.4 Nebulizers - Market size and forecast 2022-2027
Exhibit 38: Chart on Nebulizers - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Nebulizers - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Nebulizers - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Nebulizers - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ million)
Exhibit 43: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Application

7.1 Market segments
Exhibit 44: Chart on Application - Market share 2022-2027 (%)
Exhibit 45: Data Table on Application - Market share 2022-2027 (%)
7.2 Comparison by Application
Exhibit 46: Chart on Comparison by Application
Exhibit 47: Data Table on Comparison by Application
7.3 Asthma - Market size and forecast 2022-2027
Exhibit 48: Chart on Asthma - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Asthma - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Asthma - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Asthma - Year-over-year growth 2022-2027 (%)
7.4 COPD - Market size and forecast 2022-2027
Exhibit 52: Chart on COPD - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on COPD - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on COPD - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on COPD - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Application
Exhibit 56: Market opportunity by Application ($ million)
Exhibit 57: Data Table on Market opportunity by Application ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 UK - Market size and forecast 2022-2027
Exhibit 83: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.9 France - Market size and forecast 2022-2027
Exhibit 87: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on France - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ million)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 3M Co.
Exhibit 107: 3M Co. - Overview
Exhibit 108: 3M Co. - Business segments
Exhibit 109: 3M Co. - Key news
Exhibit 110: 3M Co. - Key offerings
Exhibit 111: 3M Co. - Segment focus
12.4 Adherium Ltd.
Exhibit 112: Adherium Ltd. - Overview
Exhibit 113: Adherium Ltd. - Product / Service
Exhibit 114: Adherium Ltd. - Key offerings
12.5 Amiko Digital Health Ltd.
Exhibit 115: Amiko Digital Health Ltd. - Overview
Exhibit 116: Amiko Digital Health Ltd. - Product / Service
Exhibit 117: Amiko Digital Health Ltd. - Key offerings
12.6 AptarGroup Inc.
Exhibit 118: AptarGroup Inc. - Overview
Exhibit 119: AptarGroup Inc. - Business segments
Exhibit 120: AptarGroup Inc. - Key offerings
Exhibit 121: AptarGroup Inc. - Segment focus
12.7 AstraZeneca Plc
Exhibit 122: AstraZeneca Plc - Overview
Exhibit 123: AstraZeneca Plc - Product / Service
Exhibit 124: AstraZeneca Plc - Key news
Exhibit 125: AstraZeneca Plc - Key offerings
12.8 Cognita Labs
Exhibit 126: Cognita Labs - Overview
Exhibit 127: Cognita Labs - Product / Service
Exhibit 128: Cognita Labs - Key offerings
12.9 Cohero Health Inc.
Exhibit 129: Cohero Health Inc. - Overview
Exhibit 130: Cohero Health Inc. - Product / Service
Exhibit 131: Cohero Health Inc. - Key offerings
12.10 Findair Sp. z o. o.
Exhibit 132: Findair Sp. z o. o. - Overview
Exhibit 133: Findair Sp. z o. o. - Product / Service
Exhibit 134: Findair Sp. z o. o. - Key offerings
12.11 Infineon Technologies AG
Exhibit 135: Infineon Technologies AG - Overview
Exhibit 136: Infineon Technologies AG - Business segments
Exhibit 137: Infineon Technologies AG - Key news
Exhibit 138: Infineon Technologies AG - Key offerings
Exhibit 139: Infineon Technologies AG - Segment focus
12.12 Novartis AG
Exhibit 140: Novartis AG - Overview
Exhibit 141: Novartis AG - Business segments
Exhibit 142: Novartis AG - Key offerings
Exhibit 143: Novartis AG - Segment focus
12.13 OPKO Health Inc.
Exhibit 144: OPKO Health Inc. - Overview
Exhibit 145: OPKO Health Inc. - Business segments
Exhibit 146: OPKO Health Inc. - Key offerings
Exhibit 147: OPKO Health Inc. - Segment focus
12.14 ResMed Inc.
Exhibit 148: ResMed Inc. - Overview
Exhibit 149: ResMed Inc. - Business segments
Exhibit 150: ResMed Inc. - Key news
Exhibit 151: ResMed Inc. - Key offerings
Exhibit 152: ResMed Inc. - Segment focus
12.15 Sensirion AG
Exhibit 153: Sensirion AG - Overview
Exhibit 154: Sensirion AG - Product / Service
Exhibit 155: Sensirion AG - Key offerings
12.16 Teva Pharmaceutical Industries Ltd.
Exhibit 156: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 157: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 158: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 159: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 160: Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Vectura Group plc
Exhibit 161: Vectura Group plc - Overview
Exhibit 162: Vectura Group plc - Product / Service
Exhibit 163: Vectura Group plc - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 164: Inclusions checklist
Exhibit 165: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 166: Currency conversion rates for US$
13.4 Research methodology
Exhibit 167: Research methodology
Exhibit 168: Validation techniques employed for market sizing
Exhibit 169: Information sources
13.5 List of abbreviations
Exhibit 170: List of abbreviations